In the IR PCa population presenting with PSA <10 ng/mL, ISUP grade group 3 and clinical stage up to cT2b, the 2012 Briganti nomogram represents an independent predictor of disease progression after predicting tumor upgrading too. This evidence concerns the gene KLK3 and neoplasm.